Freedonia In The News

Article Title: Metabolix Opens First European Office
Publication: MarketWatch, 4/18/2012
Freedonia Study: World Bioplastics (2823)

Quote from article
According to the Freedonia Group(1), global demand for bioplastics is expected to more than triple through 2015, with Western Europe remaining the largest consumer of bioplastic materials. With more than 700 issued and pending patents, Metabolix has led the industry in the development of a family of biopolymers called PHAs (polyhydroxyalkanoates). Metabolix's technology platform has led to the development of a line of biopolymer resins marketed under the Mirel(TM) and Mvera(TM) brands, as well as the development of biobased industrial chemicals as "drop in" replacements for petroleum-based products.
Display Full Text of Article

Return to Document